Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-018680

Options or other derivatives

  • Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BAILEY DON M · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-01 Grant or award : show line 1 in the form Stock Option (right to buy) +50,000 50,000 D
Loading xslF345X03/ownership.xml…